A new study at Moffitt Cancer Center could offer hope to people with melanoma, the deadliest form of skin cancer.
Researchers are investigating whether an injectable known as PV-10 can shrink tumors and reduce the spread of cancer. PV-10 is a solution developed from Rose Bengal, a water-soluble dye commonly used to stain damaged cells in the eye. Early clinical trials show PV-10 can boost immune response in melanoma tumors, as well as the blood stream.
“Various injection therapies for melanoma have been examined over the past 40 years, but few have shown the promising results we are seeing with PV-10,” said Shari Pilon-Thomas, Ph.D., assistant member of Moffitt’sImmunology Program.
In the initial study, researchers injected a single dose of PV-10 into mice with melanoma. The result was a significant reduction in the skin cancer lesions, as well as a sizable reduction in melanoma tumors that had spread to the lungs. The researchers said the dye solution appeared to produce a robust anti-tumor immune response and may be safer than existing immunological agents.
“We are currently in the middle of our first human clinical trial of PV-10 for advanced melanoma patients. In addition to monitoring the response of injected melanoma tumors, we are also measuring the boost in the anti-tumor immune cells of patients after injection,” explained Amod A. Sarnaik, M.D., assistant member of Moffitt’s Cutaneous Oncology Program.
The Latest on: Melanoma
- Melanoma Research at University of Iowa on April 17, 2019 at 8:00 am
Melanoma is the deadliest form of skin cancer because it easily spreads to other vital organs and is hard to fight. Dr. Michael Henry from University of Iowa Hospitals explains the newest melanoma ... […]
- Melanoma Monday: The fight against skin cancer begins in your head – act now on April 17, 2019 at 4:41 am
A melanoma skin cancer campaign has been launched to raise awareness and promote the prevention, early detection and treatment of the commonest skin-related cause of death worldwide. Monday 6 May will ... […]
- It's Melanoma Awareness Month. Pledge to take better care of your skin. on April 16, 2019 at 2:37 pm
It's Melanoma Awareness Month. Pledge to take better care of your skin. The American Cancer Society says more than 96,000 new melanomas will be diagnosed in 2019, and 7,230 people will die from ... […]
- Acral Lentiginous Melanoma Market 2019 – 2025 Analysis Scrutinized in new research | Chiron Corporation, Prometheus Laboratories, on April 16, 2019 at 7:37 am
The report on the global Acral Lentiginous Melanoma market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including ... […]
- New treatment available for non-melanoma skin cancer on April 16, 2019 at 5:22 am
PHOENIX (3TV/CBS 5) --More people have skin cancer than any other cancer and the numbers just keep rising. In fact, more than 3.5 million cases are diagnosed in the U.S. each year and experts say the ... […]
- Mechanism of resistance to BRAF inhibitors in melanoma identified on April 15, 2019 at 1:41 pm
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these positive ... […]
- Researchers identify mechanism of resistance to BRAF inhibitors in melanoma on April 15, 2019 at 9:14 am
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these ... […]
- ONS Chapter Addresses Prevention, Early Detection of Melanoma Through “Hairstylist Melanoma Challenge” on April 13, 2019 at 5:45 pm
The following article features coverage from the Oncology Nursing Society (ONS) 2019 Annual Congress. Click here to read more of Oncology Nurse Advisor‘s conference coverage. ANAHEIM, CA — Learning of ... […]
- New liquid biopsy technique used to assess melanoma progression on April 11, 2019 at 11:45 am
When the surgeon surgically removes a melanoma, some patients are said to be 'cancer-free' and they do not get additional treatment. However, should the fluid obtained in the drainage implanted after ... […]
- Butch Stearns Hosts Melanoma Prevention Foundation Event on April 9, 2019 at 2:18 pm
The Children's Melanoma Prevention Foundation (CMPF) honored Representative Kate Hogan with its second annual "Excellence in Melanoma Prevention Award" at its recent spring fundraising event. […]
via Google News and Bing News